REQUEST A DEMO
Total
USD $0.00
Search more companies

Sopharma Trading D.O.O. (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sopharma Trading D.O.O. Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Sopharma Trading D.O.O. is a company based in Serbia, with its head office in Belgrade. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on February 05, 1992. 326 (2024) employees currently work for Sopharma Trading D.O.O.. In 2025, the company reported a net sales revenue increase of 15.01%. Its’ total assets recorded a growth of 19.77%. The net profit margin of Sopharma Trading D.O.O. increased by 0.81% in 2025.

Headquarters
Viline Vode bb
Belgrade; Belgrade;

Contact Details: Purchase the Sopharma Trading D.O.O. report to view the information.

Website: http://www.lekovit.co.rs

Basic Information
Total Employees:
Purchase the Sopharma Trading D.O.O. report to view the information.
Registered Capital:
Purchase the Sopharma Trading D.O.O. report to view the information.
Financial Auditors:
Purchase the Sopharma Trading D.O.O. report to view the information.
Incorporation Date:
February 05, 1992
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Apotekarska Ustanova Sopharmacy
100%
Au Great Pharmacy
Company Performance
Financial values in the chart are available after Sopharma Trading D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
15.01%▲
Total Operating Revenue
15.06%▲
Operating Profit
N/A
EBITDA
244.26%▲
Net Profit/Loss for the Period
43.41%▲
Total Assets
19.77%▲
Total Equity
-20.26%▼
Operating Profit Margin
N/A
Net Profit Margin
0.81%▲
Return on Equity (ROE)
10.41%▲
Debt / Equity
169.84%▲
Quick Ratio
-0.11%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?